With the cases of omicron variants on the rise, the administration has been forced to take some major steps. The development of booster shots has been a game-changer to fight against the delta variant and its effective results are yet to be analyzed by the scientists whether the booster shot can play an important role in fighting against the omicron variant or not.
Variant Specific Vaccine Might Be The Need Of The Hour Stated
Dr. Anthony Fauci has been a great admirer of booster shots and has claimed that it is a must for the eligible people in the US to avail the benefits of booster shots so that they stay prevented from the infection.
The major vaccine manufacturing players in the US, Pfizer, Moderna, and Johnson & Johnson have been working continuously on developing an effective vaccine that can beat the omicron variant for a long time.
As per the US Centers for Disease Control and Prevention, the studies have found that the effectiveness and efficiency of the initial doses of the vaccines are diminishing with the passage of time. This has raised many questions on the vaccine developers in the country and has forced them to work on optimizing the current vaccines.
The CEO of Pfizer has also acknowledged the current scenario of emerging new variants in the world and has claimed that there will be a dire need for the third vaccine and by the end of the next year the need for the fourth dose of the vaccine will also arise.
Although the CEO of Moderna has also stated that the company’s scientists have already started to develop the new vaccine and we are confident it will be developed within 100 days. Since Moderna has already been into producing the initial dose of the vaccines, the organization has announced that the company will also start developing the booster dose that will focus only on the omicron variant. It is expected that the company may start the clinical trial in the year 2022.
Moderna can begin with the process in a few weeks to remain on a safer side and provide people with alternatives to protect themselves from omicron.
The CEO of Moderna Stephane Bancel has stated in an interview that the company has started its process to produce variant-specific vaccines.
On the other hand, last week the Chief Medical Consultant of the US, Dr. Anthony Fauci announced that the country is not looking forward to developing a strain-specific vaccine, rather the vaccine manufacturing companies must focus on enhancing the currently available vaccine doses.
The focus right now is on the production of the omicron booster vaccine. Our scientists are also working on analyzing the current data and information available on the new variant as well to be more sure of the vaccines being developed. The responsibility of the state has increased as the different strains keep coming up.
The earlier days of pandemics have been a lesson for such companies and that is why they are well prepared now. People must get vaccinated very soon in order to be eligible to receive the booster shot.